2-Geranyl-1-methoxyerythrabyssin II alleviates lipid accumulation and inflammation in hepatocytes through AMPK activation and AKT inhibition.
Arch Pharm Res
; 46(9-10): 808-824, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37782374
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Non-alcoholic Fatty Liver Disease
Limits:
Animals
/
Child
/
Humans
Language:
En
Journal:
Arch Pharm Res
Year:
2023
Type:
Article
Affiliation country:
China